retatrutide ada 2025 results Lilly's triple agonist achieves 16.8% weight loss in phase 3 trial ADA 2026: TRANSCEND-T2D-1: Retatrutide Demonstrates
Pay in 4 interest-free payments of $6.18 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14




























